In vitro antibacterial activity of vanadate and vanadyl compounds against Streptococcus pneumoniae.
All of the vanadate and vanadyl compounds tested in this study showed potent antibacterial activity against Streptococcus pneumoniae: the MIC (minimum inhibitory concentration) values of the vanadium compounds were 4-32 micrograms/ml, while the MIC values of tungstates and molybdates were 128-->8000 micrograms/ml. Scanning electron microscopy showed the elongation of S. pneumoniae strains under low concentrations (< MIC) of vanadium compounds such as (tert-BuNH3)4[V4O12] (1), (tert-BuNH3)6[V10O28] (2), Na3VO4 (7) and VOSO4 (8). The vanadium compounds non-selectively inhibited the incorporation of thymidine, uridine, leucine and glucose into the cells of S. pneumoniae and led to an efflux of potassium ions from the cells. It implies that the vanadium compounds interfere in or on the cell membrane with the transport of substrates and ions through the cell membrane, resulting in antibacterial activity against S. pneumoniae cells.
Fukuda
N
N
Research Laboratory of Resources Utilization, Tokyo Institute of Technology, Yokohama, Japan.
Yamase
T
T
D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D008826:Microbial Sensitivity Tests; D008855:Microscopy, Electron, Scanning; D010403:Penicillin Resistance; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D014638:Vanadates / Q000494:pharmacology*
D014638:Vanadates